Carlos Castañeda Altamirano

14PUBLICATIONS
100CO-AUTHORS
Predictive and prognostic markersSolid tumoursMidwifery not elsewhere classifiedEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 31, 2026
Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple-Negative Breast Tumours.

|Jan 12, 2026
Giant Primary Hepatic Endodermal Sinus Tumor: Multidisciplinary Management and Long-Term Survival.

Katia Roque, Rossana Ruiz, Renier Cruz

|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|Dec 03, 2024
Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.

Xiaosong Huang, Paul C Lott, Donglei Hu

|Jul 04, 2024
Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer.

Iris Otoya, Natalia Valdiviezo, Zaida Morante

|Oct 29, 2022
Association between PIK3CA Mutations in Blood and Tumor-Infiltrating Lymphocytes in Peruvian Breast Cancer Patients.

Carlos A Castaneda, Miluska Castillo, Luis A Bernabe

Pageof 3

Frequent Collaborators

9 joint publications

Miluska Castillo

7 joint publications

Luis Bernabe

6 joint publications

Joselyn Sanchez

5 joint publications

Julio E Abugattas